Studies have shown that IGF-1 LR3 has a prolonged half-life, enhancing its effectiveness in promoting muscle growth, cell proliferation, and fat metabolism
Phase 2 data showed 24.2% mean weight loss at 48 weeks with 12 mg dose, the highest weight reduction reported for any single anti-obesity agent in Phase 2 trials, exceeding survodutide's 18.7%
no constituyen orientacin de seguridad o eficacia
Periodic measurements of both urinary albumin excretion and GFR in high risk patients are advisable
Those with chronic kidney disease require specialized guidance, as high protein intake may not be appropriate
In a way, it was very clear that it wasn't just from the pregnancy because I've been pregnant six times, so this is not new to me, Oliviara said